Iradimed (IRMD) Short-term Investments (2013 - 2022)

Iradimed (IRMD) has 10 years of Short-term Investments data on file, last reported at $500090.0 in Q1 2022.

• Quarterly Short-term Investments fell 73.72% year-over-year to $500090.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $500090.0 (down 73.72% YoY) and the FY2021 annual result came in at $501855.0, down 73.72% from the prior year.
• Short-term Investments steadied at $500090.0 in Q1 2022 per IRMD's latest filing, from $501855.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $8.2 million in Q2 2018 and bottomed at $500090.0 in Q1 2022.
• The 5-year median for Short-term Investments is $2.8 million (2019), against an average of $3.6 million.
• The widest annual swing landed in 2018, when Short-term Investments climbed 16.34%; it then plunged 73.72% in 2022.
• Tracing IRMD's Short-term Investments over 5 years: stood at $6.3 million in 2018, then slumped by 56.4% to $2.8 million in 2019, then slumped by 31.03% to $1.9 million in 2020, then tumbled by 73.72% to $501855.0 in 2021, then dropped by 0.35% to $500090.0 in 2022.
• Per Business Quant, the three latest IRMD Short-term Investments figures stand at $500090.0 (Q1 2022), $501855.0 (Q4 2021), and $945066.0 (Q3 2021).

Peer Comparison